Maynard Um
-
-
-
-
-
-
-
Goldman Sachs Starts GRAIL, Inc. (GRAL) at Neutral
-
-
-
-
-
-
-
Superpower partners with GRAIL to offer multi-cancer blood test
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) Tops Q4 EPS by 157c
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) PT Raised to $105 at Canaccord Genuity
-
-
-
-
-
-
-
GRAIL study shows cancer test positive predictive value rises to 84.2%
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) PT Raised to $43 at Canaccord Genuity, 'We believe the shares do not reflect the company's growth potential'
-
-
-
-
-
-
-
Morgan Stanley Starts GRAIL, Inc. (GRAL) at Equalweight
-
451,567 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

